Just playing around over the past week to pass time whilst waiting for this update.
But on the serious side I think that BIO has been overpunished by Mr Market over the past few months .
It could be because investors want to derisk during these volatile times , tax selling , profit taking or sector changing.to greener pastures.
I have listened to the recent webinar on numerous occassions and whilst I realise that they can put a spin on the webinar in my opinion I think that Mr Market has got the situation wrong but then I know nothing. It is well worth listening to the webinar. https://investorhub.biomeaustralia.com/announcements/6978954
From what I can understand sales are growing expotentially, margins are good, profitability is approaching quickly, new products are being rolled out and the international rollout is being pursued slowly and actively in a calculated manner. Canada, UK, Ireland and NZ.
It good to see the increase in revenue and its inaugral full year of net profit in the FY 25 accounts ( I guess subject to audit) even after they have incurred extensive set up costs for the international rollout.
Great to see that they are ontrack to achieve its Vision FY 27 forecast.
It will be interesting to see what Mr Market does subject to market vagries now that tney have had time to digest the latest news. Looking forward to the next detailed update
Follow your own path.
DYOR
BIO Price at posting:
57.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)